SBFM SUNSHINE BIOPHARMA INC Capital Structure Changes 8-K Filing 2024 - Agreement and Reverse Stock Split Sunshine Biopharma, Inc. agreed to sell 100,000 shares of Series B Preferred Stock to its CEO for $10,000 and approved a reverse stock split to regain compliance with Nasdaq rules.Get access to all SEC 8-K filings of the SUNSHINE BIOPHARMA INC